GenMark Diagnostics to Present at Canaccord Genuity 32nd Annual Growth Conference

Published: Aug 15, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc., (NASDAQ:GNMK) a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the Canaccord Genuity 32nd Annual Growth Conference to be held at the InterContinental Boston hotel in Boston, Massachusetts today.

Back to news